Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study | July 23
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully @ and safely @ dosing its first patient with RC220 and RC220 in combination with doxorubicin.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines ...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IPR | nearmap – the cash cow has started mooing | 21/02/13 | 0 | 1.1K | |||
|
|||||||
IPR | simon crowther | 05/12/12 | 26 | 8.6K | |||
|
|||||||
IPR | one more mouth to feed... | 03/12/12 | 18 | 3.9K | |||
|
|||||||
IPR | nearmap staff turnover at the top... :( | 30/11/12 | 3 | 2.0K | |||
|
|||||||
IPR | Ann: Change of Company Name and Registered Office | 29/11/12 | 0 | 889 | |||
|
|||||||
IPR | Ann: 2012 AGM Presentation | 28/11/12 | 5 | 1.9K | |||
|
|||||||
IPR | Ann: Appointment of new Chief Financial Officer | 28/11/12 | 4 | 3.5K | |||
|
|||||||
IPR | Ann: Change of Director's Interest Notice - C | 28/11/12 | 0 | 696 | |||
|
See All Discussions